Real-World Effectiveness of Pegloticase Associated With Use of Concomitant Immunomodulatory Therapy.

Emily E HolladayAmy S MudanoFenglong XieJingyi ZhangTed R MikulsKenneth G Saag Huifeng Yun Brian LaMoreaux Megan Francis Sedlak Jeffrey R Curtis

Published in: Arthritis care & research (2024)

Consistent with clinical trials, results from this large observational registry suggest that concomitant immunomodulatory drug treatment improves pegloticase persistence.

Keyphrases

clinical trial
randomized controlled trial
systematic review
stem cells
cross sectional
mesenchymal stem cells
combination therapy
phase ii
open label
adverse drug
study protocol
cell therapy